ZA921270B - Peptides for treatment - Google Patents

Peptides for treatment

Info

Publication number
ZA921270B
ZA921270B ZA921270A ZA921270A ZA921270B ZA 921270 B ZA921270 B ZA 921270B ZA 921270 A ZA921270 A ZA 921270A ZA 921270 A ZA921270 A ZA 921270A ZA 921270 B ZA921270 B ZA 921270B
Authority
ZA
South Africa
Prior art keywords
absent
thr
ser
gly
cys
Prior art date
Application number
ZA921270A
Other languages
English (en)
Inventor
Ove Pedersen
Pedersen Ove
D K Macfadden
K Macfadden D
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of ZA921270B publication Critical patent/ZA921270B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA921270A 1991-02-25 1992-02-21 Peptides for treatment ZA921270B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK031991A DK31991D0 (da) 1991-02-25 1991-02-25 Peptid og farmaceutisk praeparat indeholdende et saadant peptid

Publications (1)

Publication Number Publication Date
ZA921270B true ZA921270B (en) 1992-11-25

Family

ID=8092219

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921270A ZA921270B (en) 1991-02-25 1992-02-21 Peptides for treatment

Country Status (13)

Country Link
US (1) US5763406A (da)
EP (1) EP0573538B1 (da)
JP (1) JP3250804B2 (da)
AT (1) ATE118349T1 (da)
AU (1) AU1377092A (da)
CA (1) CA2101075C (da)
DE (1) DE69201438T2 (da)
DK (2) DK31991D0 (da)
ES (1) ES2070635T3 (da)
GR (1) GR3015888T3 (da)
IE (1) IE69853B1 (da)
WO (1) WO1992014751A1 (da)
ZA (1) ZA921270B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
DK0871466T3 (da) * 1993-09-24 2004-08-16 Advanced Immuni T Inc Lineære og cykliske peptider til behandling eller forebyggelse af eksem/dermatitis
US6458766B1 (en) 1998-12-15 2002-10-01 The Regents Of The University Of California Halovir, an antiviral marine natural product, and derivatives thereof
US6613507B1 (en) 2000-03-21 2003-09-02 Yu-an Chang Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
US7374068B2 (en) * 2004-10-08 2008-05-20 Homax Products, Inc. Particulate materials for acoustic texture material
EP3590533A1 (en) 2009-05-22 2020-01-08 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
EP2643014A4 (en) 2010-11-24 2015-11-11 Genocea Biosciences Inc HERPES SIMPLEX TYPE 2 VIRUS VACCINES: COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CA2885693C (en) 2011-11-23 2020-07-28 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
WO2018064232A1 (en) 2016-09-28 2018-04-05 Genocea Biosciences, Inc. Methods and compositions for treating herpes
US12036286B2 (en) 2021-03-18 2024-07-16 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190127A1 (en) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutic polypeptide agents
US4585587A (en) * 1984-10-19 1986-04-29 Northwestern University Antigenic peptide compounds
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima
WO1987007614A1 (en) * 1986-06-03 1987-12-17 Pert Candace B Small peptides which inhibit binding to t-4 receptors
EP0249394B1 (en) * 1986-06-03 1993-10-27 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens
AU1808088A (en) * 1987-05-22 1988-12-21 Syntbiotech, Inc. Synthetic peptides and a method of treating aids
JPH0618777B2 (ja) * 1988-05-27 1994-03-16 アメリカ合衆国 精神神経性欠損症の治療に用いられる組成物
DE3841761A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides

Also Published As

Publication number Publication date
CA2101075A1 (en) 1992-08-26
DK0573538T3 (da) 1995-06-26
AU1377092A (en) 1992-09-15
DK31991D0 (da) 1991-02-25
US5763406A (en) 1998-06-09
GR3015888T3 (en) 1995-07-31
DE69201438D1 (en) 1995-03-23
IE920496A1 (en) 1992-08-26
EP0573538B1 (en) 1995-02-15
DE69201438T2 (de) 1995-10-05
JPH06507386A (ja) 1994-08-25
CA2101075C (en) 2003-04-22
ATE118349T1 (de) 1995-03-15
ES2070635T3 (es) 1995-06-01
IE69853B1 (en) 1996-10-02
WO1992014751A1 (en) 1992-09-03
JP3250804B2 (ja) 2002-01-28
EP0573538A1 (en) 1993-12-15

Similar Documents

Publication Publication Date Title
GR3015888T3 (en) Peptides for treatment.
EP1077070A3 (en) Oral drug delivery compositions
NZ502872A (en) Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases
MD1652F2 (en) Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein
ZA9394B (en) A novel human kunitz-type inhibitor and variants thereof
HK1160778A1 (en) Pharmaceutical composition comprising an analgesic peptide
ATE162201T1 (de) Cnp-gen und vorläuferprotein aus schwein
CA2002924A1 (en) Anti-Thrombins
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
CA2025070A1 (en) Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
CA2102606A1 (en) Compositions for the treatment of chronic fatigue syndrome
CA2196308A1 (en) Peptide, bronchodilator and blood flow ameliorant
ATE124955T1 (de) Substrat-peptide.
AU6354298A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
HK1013622A1 (en) Pharmaceutical lysine-containing polypeptide compositions and the use thereof
EP0687685A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES
ATE92078T1 (de) Pharmakologisch aktive peptide.
CA2216704A1 (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
CA2102447A1 (en) Cyclopeptides
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция